10978_004_flag_800
Download Brochure
Email Updates
Testimonials
“We thoroughly enjoyed the eye-opening seminars. BioBusiness allows a more intimate, honest and constructive exchange of opinions than other conferences.” Rami Suzuki, Senior Manger, Oncology, Eisai

Event Highlights From 2009

BioBusiness 2009 hosted over 70 senior speakers from across the world who shared their experience and objectives in partnering and M&A in 2009. Key speakers sharing their strategies included:
 
  • Michael Schultz, VP New Business Ventures, Global BD&L, Bayer Schering Pharm
  •  Anthony Hoerning, Head Global Alliance Management, General Medicines, Novartis Pharma
  • Shelagh Wilson, VP Business Opportunities, GlaxoSmithKline
  • Joern Peter Halle, Head of Early Stage Licensing, Merck Serono
  • Klaus Wilgenbus, Corporate Senior VP Licensing, Boehringer Ingelheim
  • Eric Rambeaux, VP Business Development, Head of Screening & Analytics, Solvay Pharmaceuticals
  • Crispin Simon, CEO, Biocompatibles
  • Jennifer Fox, Investment Banking Healthcare, Deutsche Bank

BioBusiness 2009 also launched a new concept for the industry: The Investment Challenge. The audience benefited from the opportunity to watch biotechs pitching both panels of investors and pharma decision makers LIVE on stage and to hear frank feedback from them.

Attendees get a unique insight into the thought process their partners go through in order to refine their pitches and target the right decision makers for success.